A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Recruiting · NCT07615426 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Recruiting | Phase 1 | 2026-09-28 | NCT07615426 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Research & Development, LLC | 188 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CNS Network | Garden Grove | United States | 2 |
| Community Clinical Research, Inc. | Austin | United States | 3 |
| Evolution Research Group | Staten Island | United States | 1 |
| Neurobehavioral Research Inc | Cedarhurst | United States | 4 |
| Pillar Clinical Research, LLC | Richardson | United States | 4 |
| Synexus Clinical Research US Inc | Atlanta | United States | 1 |
| Uptown Research Institute | Chicago | United States | 12 |
| Western Michigan University | Kalamazoo | United States | 4 |